These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9572212)

  • 21. Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
    Hentschel K; Fleckenstein AE; Toney TW; Lawson DM; Moore KE; Lookingland KJ
    Brain Res; 2000 Jan; 852(1):28-36. PubMed ID: 10661492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin-related testosterone secretion in normal adult men.
    Rubin RT; Poland RE; Tower BB
    J Clin Endocrinol Metab; 1976 Jan; 42(1):112-6. PubMed ID: 1249179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
    Valensi P; Combes ME; Perret G; Attali JR
    J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperprolactinemia and immunohistochemical expression of intracellular prolactin and prolactin receptor in primary central nervous system tumors and their relationship with cellular replication.
    Soares Leães CG; Filho AP; Pereira Lima JF; Dallago CM; Batista RL; Barbosa-Coutinho LM; Ferreira NP; da Costa Oliveira M
    Brain Tumor Pathol; 2007; 24(2):41-6. PubMed ID: 18095129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women.
    Larrea F; Escorza A; Valencia X; Méndez I; Schiavon R; Forsbach G
    Rev Invest Clin; 1991; 43(4):293-8. PubMed ID: 1798861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
    Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
    Rao R; Scommegna A; Frohman LA
    Am J Obstet Gynecol; 1982 Aug; 143(8):883-7. PubMed ID: 7102764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced prolactin secretion in patients with primary hypothyroidism during thyroid replacement.
    Sato S; Hanew K; Sasaki A; Shimizu Y; Murakami O; Fukazawa H; Sakurada T; Saito S; Yoshinaga K
    Tohoku J Exp Med; 1984 Dec; 144(4):425-31. PubMed ID: 6528338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders.
    Takechi K; Yoshioka Y; Kawazoe H; Tanaka M; Takatori S; Kobayashi M; Matsuoka I; Yanagawa H; Zamami Y; Imanishi M; Ishizawa K; Tanaka A; Araki H
    Biol Pharm Bull; 2017; 40(10):1775-1778. PubMed ID: 28966250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography.
    Shangold GA; Kletzky OA; Marrs RP; Mishell DR
    Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of dopaminergic inhibition on serum levels of thyrotrophin and prolactin in patients with hypothyroidism before and after prolonged oral administration of TRH.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):183-8. PubMed ID: 6415988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of haloperidol and prolactin secreting tumors on cerebrospinal fluid concentrations of prolactin in the female rat.
    Simpkins JW
    Life Sci; 1992; 51(4):295-301. PubMed ID: 1625521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin hyperstimulation in response to thyrotropin-releasing hormone in patients with endometriosis.
    Muse K; Wilson EA; Jawad MJ
    Fertil Steril; 1982 Oct; 38(4):419-22. PubMed ID: 6811338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
    Roke Y; van Harten PN; Boot AM; Buitelaar JK
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperprolactinemia in hypothyroidism: effects of L-thyroxine therapy].
    Velardo A; Toschi E; Pantaleoni M; Coletta F; Menozzi R; Marrama P
    Minerva Endocrinol; 1994 Mar; 19(1):1-4. PubMed ID: 8035765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.